171 related articles for article (PubMed ID: 21177208)
21. Extramedullary haematopoiesis in axillary lymph nodes following neoadjuvant chemotherapy for locally advanced breast cancer--a potential diagnostic pitfall.
Millar EK; Inder S; Lynch J
Histopathology; 2009 Apr; 54(5):622-3. PubMed ID: 19413641
[No Abstract] [Full Text] [Related]
22. [Conservative surgery for T2 > 3 cm, T3 N0 N1 M0 breast cancer after induction chemotherapy].
Bobin JY; Zinzindohoue C; Faure Virelizier C; Joulai A; Khaled M
Bull Cancer; 2001 Feb; 88(2):175-80. PubMed ID: 11257592
[TBL] [Abstract][Full Text] [Related]
23. [Breast-conserving surgery in breast cancer].
Ruggiero R; Procaccini E; Freda F; Iovino F; Irlandese E; Gili S; Lo Schiavo F
G Chir; 2005; 26(11-12):449-52. PubMed ID: 16472427
[TBL] [Abstract][Full Text] [Related]
24. [Role of lymph node irradiation in breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy: the René-Huguenin Cancer Center experience].
Daveau C; Stevens D; Labib A; Berges O; Moisson P; De la Lande B; Le Scodan R
Cancer Radiother; 2010 Dec; 14(8):711-7. PubMed ID: 20674445
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer.
Koslow SB; Eisenberg RE; Qiu Q; Chen Z; Swistel A; Shin SJ
Am Surg; 2014 Feb; 80(2):171-7. PubMed ID: 24480218
[TBL] [Abstract][Full Text] [Related]
26. Management of non-inflammatory locally advanced breast cancer: focus on surgical approaches.
Eroğlu A; Aydin F
Exp Oncol; 2013 Dec; 35(4):272-9. PubMed ID: 24382437
[TBL] [Abstract][Full Text] [Related]
27. [The advantages of preoperative systemic therapy in breast cancer].
Mieog JS; van Nes JG; van de Velde CJ
Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2501-6. PubMed ID: 19055256
[TBL] [Abstract][Full Text] [Related]
28. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
30. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
31. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R
J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
[TBL] [Abstract][Full Text] [Related]
33. Pathological controversies in breast cancer: classification of ductal carcinoma in situ, sentinel lymph nodes and low volume metastatic disease and reporting of neoadjuvant chemotherapy specimens.
Provenzano E; Brown JP; Pinder SE
Clin Oncol (R Coll Radiol); 2013 Feb; 25(2):80-92. PubMed ID: 23199579
[TBL] [Abstract][Full Text] [Related]
34. Clear margins for invasive lobular carcinoma: a surgical challenge.
Sakr RA; Poulet B; Kaufman GJ; Nos C; Clough KB
Eur J Surg Oncol; 2011 Apr; 37(4):350-6. PubMed ID: 21277728
[TBL] [Abstract][Full Text] [Related]
35. Surgical treatment of early breast cancer in day surgery.
Marrazzo A; Taormina P; David M; Riili I; Lo Gerfo D; Casà L; Noto A; Mercadante S
Chir Ital; 2007; 59(5):687-91. PubMed ID: 18019641
[TBL] [Abstract][Full Text] [Related]
36. Extramedullary Haematopoiesis in Axillary Lymph Nodes of Breast Carcinoma Patients Receiving Neoadjuvant Chemotherapy: A Potential Diagnostic Pitfall.
Badr NM; Roberts C; Shaaban AM
Pathobiology; 2019; 86(2-3):167-172. PubMed ID: 30423570
[TBL] [Abstract][Full Text] [Related]
37. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer.
Hieken TJ; Boughey JC; Jones KN; Shah SS; Glazebrook KN
Ann Surg Oncol; 2013 Oct; 20(10):3199-204. PubMed ID: 23846781
[TBL] [Abstract][Full Text] [Related]
38. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M
Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472
[TBL] [Abstract][Full Text] [Related]
39. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
[TBL] [Abstract][Full Text] [Related]
40. [Conservative approach for breast cancer. The experience of the European Institute of Oncology].
Gentilini O; Veronesi P; Gatti G; Intra M; Mazzarol G; Trifirò G; Bassi F; Caliskan M; Da Lima L; Galimberti V; Luini A
Minerva Chir; 2007 Dec; 62(6):447-58. PubMed ID: 18091655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
